Cargando…
Plasma miRNA can detect colorectal cancer, but how early?
Colorectal cancer (CRC) is a major cause of deaths worldwide but has a good prognosis if detected early. The need for efficient, preferable non‐ or minimally invasive, inexpensive screening tools is therefore critical. We analyzed 12 miRNAs in pre‐ and postdiagnostic plasma samples to evaluate their...
Autores principales: | Wikberg, Maria L., Myte, Robin, Palmqvist, Richard, van Guelpen, Bethany, Ljuslinder, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943420/ https://www.ncbi.nlm.nih.gov/pubmed/29573205 http://dx.doi.org/10.1002/cam4.1398 |
Ejemplares similares
-
Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
por: Sundkvist, Anneli, et al.
Publicado: (2019) -
One‐carbon metabolite ratios as functional B‐vitamin markers and in relation to colorectal cancer risk
por: Gylling, Björn, et al.
Publicado: (2018) -
The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
por: Harlid, Sophia, et al.
Publicado: (2017) -
Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent Risk of Colorectal Cancer and Molecular Tumor Subtypes
por: Bodén, Stina, et al.
Publicado: (2023) -
A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
por: Harlid, Sophia, et al.
Publicado: (2021)